Boiron Overview

  • Founded
  • 1932
Founded
  • Status
  • Public
  • Employees
  • 3,227
Employees
  • Stock Symbol
  • BOI
Stock Symbol
  • Investments
  • 2
  • Share Price
  • $40.59
  • (As of Friday Closing)

Boiron General Information

Description

Boiron is a drug manufacturer that focuses on homeopathic products. The company's revenue is roughly split between its nonproprietary homeopathic medicines and products in its over-the-counter specialties category. Boiron's nonproprietary medicines are generic products that do not refer to any therapeutic indication, while the specialties category includes first-resort products provided in tablet form, are bottled to use as drops, syrups, or ointments. Geographical segments are France, Europe, North America, and other countries. It generates a majority of revenue from France. The company's products include Oscillococcinum, Stodal and Stodaline, Arnigel, Camilia, Sedatif PC, Coryzalia, Homeoptic, and Homeovox.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Stock Exchange
PAR
Primary Office
  • 4 Campus Boulevard
  • Newtown Square, PA 19073-3267
  • United States
+1 (800) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Boiron Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$40.59 $41.43 $39.65 - $53.96 $726M 17.5M 5.5K $1.22

Boiron Financials Summary

In Thousands,
USD
TTM 30-Jun-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 532,475 659,552 526,075 779,014
Revenue 536,286 585,439 623,668 713,010
EBITDA 66,812 78,388 108,579 159,456
Net Income 21,064 29,876 45,483 67,805
Total Assets 873,756 961,614 856,128 877,462
Total Debt 12,416 15,288 14,580 6,854
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Boiron Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Boiron‘s full profile, request access.

Request a free trial

Boiron Patents

Boiron Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
FR-2995534-A1 Use of gelsemium and/or gelsemine as homeopathic or allopathic drug and neurotrophic agent and/or neuroprotective agent for treating and preventing neurodegenerative disease, preferably alzheimer's disease and parkinson's disease Granted 17-Sep-2012 0000000000
FR-2995534-B1 Medicament with neurotrophic, neuroprotective and / or anti-neurodegenerative activity Active 17-Sep-2012 0000000000
CA-2816283-A1 Method and installation for production of compresses having a cooling effect, and compresses obtained in sterile packaging Granted 26-Oct-2010 0000000000
US-20130218245-A1 Method and installation for production of compresses having a cooling effect, and compresses obtained in sterile packaging Granted 26-Oct-2010 0000000000 00
US-9717624-B2 Apparatus and method for producing compresses having a cooling effect Active 26-Oct-2010 A61F7/0241 00

Boiron Executive Team (4)

Name Title Board Seat Contact Info
Christian Boiron Co-Chief Executive Officer & Director
Thierry Boiron President
Ron Gentry Vice President of Marketing
You’re viewing 3 of 4 executive team members. Get the full list »

Boiron Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Boiron Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Boiron‘s full profile, request access.

Request a free trial

Boiron Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000000 0 07-Apr-2017 0000000000 00.000 Laboratory Services (Healthcare) 0000000 0
Laboratoires Dolisos 01-Jan-2005 Merger/Acquisition Distributors (Healthcare)
To view Boiron’s complete acquisitions history, request access »